C12Y 302/01178
Beta-porphyranase
Official title: Beta-porphyranase (3.2.1.178)
C12Y302/01178 (Beta-porphyranase) appears on 3 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 8
- Assignees
- 5
- Inventors
- 18
- Latest grant
- 31 Jan 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 2 |
By publication year.
Recent patents
- Compositions and methods for modulating growth of a genetically modified gut bacterial cell31 Jan 2023US 11,566,238 B2Novome Biotechnologies, Inc.
- Compositions and methods for modulating growth of a genetically modified gut bacterial cell22 Feb 2022US 11,254,918 B2Novome Biotechnolooies, Inc.
- Porphyranases, and use thereof for hydrolyzing polysaccharides24 Jun 2014US 8,759,039 B2Centre National de la Recherche Scientifique (CNRS)
- Compositions and Methods for Modulating Growth of a Genetically Modified Gut Bacterial Cell18 Apr 2024US 2024/0124861 A1Novome Biotechnologies, Inc.
- Compositions and methods for modulating growth of a genetically modified gut bacterial cell7 Mar 2024US 2024/0076641 A1Novome Biotechnologies, Inc.
- Compositions and Methods for Modulating Growth of a Genetically Modified Gut Bacterial Cell9 Jun 2022US 2022/0177866 A1Novome Biotechnologies, Inc.
- Compositions and Methods for Modulating Growth of a Genetically Modified Gut Bacterial Cell25 Feb 2021US 2021/0054356 A1Novome Biotechnologies, Inc.
- Compositions and methods for modulating growth of a genetically modified gut bacterial cell19 Mar 2020US 2020/0085884 A1Novome Biotechnologies, Inc.
Most cited
By later US patents